FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108183713> ?p ?o ?g. }

• W2108183713 endingPage "2040" @default.
• W2108183713 startingPage "2031" @default.
• W2108183713 abstract "Triple negative (TN) breast cancer is more frequent in women who are obese or have type II diabetes, as well as young Women of Color. These cancers do not express receptors for the steroid hormones estrogen or progesterone, or the type II receptor tyrosine kinase (RTK) Her-2 but do have upregulation of basal cytokeratins and the epidermal growth factor (EGFR). These data suggest that aberrations of glucose and fatty acid metabolism, signaling through EGFR and genetic factors may promote the development of TN cancers. The anti-type II diabetes drug metformin has been associated with a decreased incidence of breast cancer, although the specific molecular subtypes that may be reduced by metformin have not been reported. Our data indicates that metformin has unique anti-TN breast cancer effects both in vitro and in vivo. It inhibits cell proliferation (with partial S phase arrest), colony formation and induces apoptosis via activation of the intrinsic and extrinsic signaling pathways only in TN breast cancer cell lines. At the molecular level, metformin increases P-AMPK, reduces P-EGFR, EGFR, P-MAPK, P-Src, cyclin D1 and cyclin E (but not cyclin A or B, p27 or p21), and induces PARP cleavage in a dose- and time-dependent manner. These data are in stark contrast to our previously published biological and molecular effects of metformin on luminal A and B, or Her-2 type breast cancer cells. Nude mice bearing tumor xenografts of the TN line MDA-MB-231, treated with metformin, show significant reductions in tumor growth (p=0.0066) and cell proliferation (p=0.0021) as compared to untreated controls. Metformin pre-treatment, before injection of MDA-MB-231 cells, results in a significant decrease in tumor outgrowth and latency. Given the unique anti-cancer activity of metformin against TN disease, both in vitro and in vivo, it should be explored as a therapeutic agent against this aggressive form of breast cancer." @default.
• W2108183713 created "2016-06-24" @default.
• W2108183713 creator A5001123822 @default.
• W2108183713 creator A5013400628 @default.
• W2108183713 creator A5019925910 @default.
• W2108183713 creator A5040828381 @default.
• W2108183713 creator A5044927129 @default.
• W2108183713 creator A5048727442 @default.
• W2108183713 creator A5070682341 @default.
• W2108183713 date "2009-07-01" @default.
• W2108183713 modified "2023-09-25" @default.
• W2108183713 title "Metformin induces unique biological and molecular responses in triple negative breast cancer cells" @default.
• W2108183713 cites W1491350259 @default.
• W2108183713 cites W1796205058 @default.
• W2108183713 cites W1852586722 @default.
• W2108183713 cites W1974130263 @default.
• W2108183713 cites W1980359753 @default.
• W2108183713 cites W1987140385 @default.
• W2108183713 cites W1988339176 @default.
• W2108183713 cites W1990063646 @default.
• W2108183713 cites W1991475591 @default.
• W2108183713 cites W1999463736 @default.
• W2108183713 cites W2015136221 @default.
• W2108183713 cites W2015996532 @default.
• W2108183713 cites W2016905164 @default.
• W2108183713 cites W2025128734 @default.
• W2108183713 cites W2026967508 @default.
• W2108183713 cites W2033351371 @default.
• W2108183713 cites W2043409879 @default.
• W2108183713 cites W2061497413 @default.
• W2108183713 cites W2064211753 @default.
• W2108183713 cites W2064656431 @default.
• W2108183713 cites W2066578460 @default.
• W2108183713 cites W2078190084 @default.
• W2108183713 cites W2087865412 @default.
• W2108183713 cites W2089531514 @default.
• W2108183713 cites W2092231118 @default.
• W2108183713 cites W2093664485 @default.
• W2108183713 cites W2097255042 @default.
• W2108183713 cites W2099335989 @default.
• W2108183713 cites W2099796212 @default.
• W2108183713 cites W2100103895 @default.
• W2108183713 cites W2102956047 @default.
• W2108183713 cites W2106705731 @default.
• W2108183713 cites W2107121249 @default.
• W2108183713 cites W2111812703 @default.
• W2108183713 cites W2119063085 @default.
• W2108183713 cites W2120512382 @default.
• W2108183713 cites W2122889158 @default.
• W2108183713 cites W2128114333 @default.
• W2108183713 cites W2128985829 @default.
• W2108183713 cites W2131994307 @default.
• W2108183713 cites W2135847690 @default.
• W2108183713 cites W2139819066 @default.
• W2108183713 cites W2141812214 @default.
• W2108183713 cites W2144209522 @default.
• W2108183713 cites W2148269604 @default.
• W2108183713 cites W2157840751 @default.
• W2108183713 cites W2161426850 @default.
• W2108183713 cites W2161770015 @default.
• W2108183713 cites W2162453996 @default.
• W2108183713 cites W2164452916 @default.
• W2108183713 cites W2166935017 @default.
• W2108183713 cites W2169862472 @default.
• W2108183713 cites W2540855722 @default.
• W2108183713 doi "https://doi.org/10.4161/cc.8.13.8814" @default.
• W2108183713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19440038" @default.
• W2108183713 hasPublicationYear "2009" @default.
• W2108183713 type Work @default.
• W2108183713 sameAs 2108183713 @default.
• W2108183713 citedByCount "352" @default.
• W2108183713 countsByYear W21081837132012 @default.
• W2108183713 countsByYear W21081837132013 @default.
• W2108183713 countsByYear W21081837132014 @default.
• W2108183713 countsByYear W21081837132015 @default.
• W2108183713 countsByYear W21081837132016 @default.
• W2108183713 countsByYear W21081837132017 @default.
• W2108183713 countsByYear W21081837132018 @default.
• W2108183713 countsByYear W21081837132019 @default.
• W2108183713 countsByYear W21081837132020 @default.
• W2108183713 countsByYear W21081837132021 @default.
• W2108183713 countsByYear W21081837132022 @default.
• W2108183713 countsByYear W21081837132023 @default.
• W2108183713 crossrefType "journal-article" @default.
• W2108183713 hasAuthorship W2108183713A5001123822 @default.
• W2108183713 hasAuthorship W2108183713A5013400628 @default.
• W2108183713 hasAuthorship W2108183713A5019925910 @default.
• W2108183713 hasAuthorship W2108183713A5040828381 @default.
• W2108183713 hasAuthorship W2108183713A5044927129 @default.
• W2108183713 hasAuthorship W2108183713A5048727442 @default.
• W2108183713 hasAuthorship W2108183713A5070682341 @default.
• W2108183713 hasBestOaLocation W21081837131 @default.
• W2108183713 hasConcept C121608353 @default.
• W2108183713 hasConcept C126322002 @default.
• W2108183713 hasConcept C134018914 @default.
• W2108183713 hasConcept C199835354 @default.
• W2108183713 hasConcept C2779438470 @default.
• W2108183713 hasConcept C2780323712 @default.

• next